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Complement-independent nephrotoxic nephritis in the guinea pig.
Immunologic mechanisms of proteinuria were investigated in
guinea pigs (GP) injected with sheep antiserum (NTS) to GP
glomerular basement membrane (GBM). Linear deposition of
sheep ', and 'Y2 IgG led to a prompt but transient (36 hr) increase
in albumin excretion from control values of 0.026 + 0.013 mg/hr
to maximal values of 26.3 12.1 mg/hr at six hours without
detectable histologic or electron microscopic changes except for
decreased staining for glomerular polyanion and epithelial cell foot
process fusion. GBM permeability to anionic ferritin was not
increased during proteinuria. Anti-GBM antibody deposits did not
fix GP C3 or C4 in vivo or in vitro. NTS-induced proteinuria was
the same in guinea pigs that were normal, > 95% depleted of C3
through C9, genetically deficient in C4, and depleted of circulating
polymorphonuclear leukocytes (PMN). Prior administration of
antihistamines, steroids, azathioprine, colchicine, indomethacin,
heparin, aprotinin (Trasylol), and niridazole also failed to reduce
proeinuria. Initial proteinuria subsided by 36 hr, did not recur
despite linear deposition of GP 'ti and 'Yz after day seven, and
could not be produced by large or repeated doses of rabbit or GP
antibody to GBM-bound sheep globulin. In the GP nephrotoxic
nephritis model, anti-GBM antibody deposits apparently mediate
increased permeability to albumin by a currently undefined mecha-
nism which is independent of complement, PMN, and other
known mediators of inflammation.
Néphrite nephrotoxique indépendante du complement chez Ic co-
haye. Les mécanismes immunologiques de Ia protéinurie ont été
étudiés chez des cobayes (GP) auxquels a été injecté de l'anti-sérum
de mouton (NTS) anti GBM (membrane basale glomerulaire) de
cobaye. Le dépôt Iinéaire des lgG y, et 'Y2 de mouton a eu pour
corrolaire une augmentation rapide mais transitoire (36 heures) de
l'excrétion d'albumine depuis des valeurs contrôles de 0,026
0,013 mg/hr jusqu'à des valeurs maximales de 26,3 12,1 mg/hr a
Ia sixiême heure, En même temps il n'était observe aucune modifi-
cation histologique ou de microscopic Clectronique autre qu'une
diminution des colorations glomérulaires par les polyanions et Ia
fusion des pieds des podocytes. La permCabilite de GBM a Ia
ferritine anionique n'a pas augmenté au cours de Ia protéinurie.
Les dépôts d'anticorps anti GBM n'ont fixé le C3 et le C4 de
cobaye ni in vitro ni in vivo. La proteinurie induite par Ic NTS a été
Ia même que les cobayes soient normaux, déplétés a plus de 95% en
C3—C9, génétiquement déficients en C4 et déplCtés en PMN circu-
lants. L'administration préalable d'antihistaminiques, de stéroides,
d'azathioprine, de colchicine, d'indomethacine, d'héparine, de
Trasylol et de niridazole n'a pas réduit Ia protéinurie. La pro-
téinurie initiale a cessé aprCs 36 heures et n'est pas réapparue mal-
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gre Ic depot !inéaire de 'y et 'Yz de cobaye après Ic 7e jour et na pas
Pu Ctre produite par des doses importantes et répétées d'anticorps
de lapin ou de cobaye anti-globuline de mouton liée a GBM. Dans
cc modéle les dCpôts d'anticorps anti GBM semblent être les me-
diateurs de l'augmentation de perméabilité a l'albumine par un
mCcanisme non défini a l'heure actuelle qui est independant de
complement, PMN et d'autres médiateurs connus de
I'inflammation.
Experimental studies of nephrotoxic nephritis(NTN) induced in the rat or rabbit by the passive
administration of heterologous antibody to glomeru-
lar basement membrane (GBM) have demonstrated
that pathogenic immunoglobulin (Ig) deposits pro-
duce proteinuria by activating a sequence of mediator
systems, which in turn bring about GBM injury [1].
The importance of the complement (C') system, poly-
morphonuclear leukocytes (PMN), and leukocytic
proteases in mediating proteinuria in the NTN model
is well documented (2—5). Similar mechanisms are
believed to be operative in the nephritis induced ex-
perimentally by immunization with GBM antigens
[6] and, by inference, in most types of immunolog-
ically-mediated renal disease in man [7].
Additional factors of apparent importance in de-
termining GBM permeability to serum proteins in-
clude glomerular hemodynamics [8, 9] and net charge
on the glomerular capillary wall [10, 11]. We have
previously reported that autologous anti-GBM an-
tibody deposition in guinea pigs, induced by immuni-
zation with human GBM antigens, results in heavy
protein uria and characteristic electron microscopic
(EM) lesions of the GBM without significant in-
flammatory changes or involvement of the C' system
[12, 13]. The present study demonstrates that admin-
istration of small amounts of heterologous anti-GBM
antibody to guinea pigs results in a prompt and
marked increase in GBM permeability to albumin,
which is not associated with histologic or EM evi-
dence of glomerular inflammation, occurs independ-
ently of the C' system, and is not altered by treatment
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with drugs which, among other effects, block various
defined mediators of the inflammatory response.
These studies confirm and extend observations re-
cently reported by Simpson et al [141 and demon-
strate that in the guinea pig significant alterations in
GBM permeability may be induced by Ig deposition
through mechanisms that do not involve C' and
PMN-mediated tissue injury. These findings may be
relevant to understanding the basic biologic mecha-
nisms of proteinuria in human glomerular disease.
Methods
General. Male, outbred Hartley strain guinea pigs
underwent injections and biopsies under general
anesthesia [15]. C4 deficient guinea pigs were raised
from animals initially obtained from the Animal Pro-
duction Section at the National Institutes of Health,
Bethesda, MD [16]. The protein content of 24-hr
urine collections and urine aspirated directly from the
bladder at intervals after nephrotoxic serum (NTS)
injection was determined by a sulfosalicylic acid
method [17], and analysis of urine protein was per-
formed by agarose gel electrophoresis and densito-
metry [18]. lgG concentrations were measured by ra-
dial immunodiffusion [19] and blood urea nitrogen
(BUN), and creatinine concentrations were measured
by standard autoanalyzer techniques.
Preparation of nephrotoxic serum (NTS). Sheep
were immunized with isolated, intact glomeruli pre-
pared from guinea pig kidneys by differential sieving
techniques [20, 21] and emulsified in complete
Freund's adjuvant (Difco Corporation, Detroit, MI).
NTS was absorbed extensively with heat-inactivated,
lyophilized, pooled guinea pig plasma and fresh red
cells. Before use, NTS was heat-inactiated at 56° for
30 miii and diluted 1: 10 in phosphate buffered saline,
pH, 7.3. A dose-response curve was obtained by ad-
ministering increasing doses to groups of five animals
weighing 230 to 250 g. To exclude any effect of non-
antibody serum constituents in NTS on proteinuria,
IgG was isolated from a 50% ammonium sulfate
precipitate of NTS by DEAE-52 cellulose column
chromatography. A second dose-response curve was
constructed using a solution of purified IgG of
equivalent concentration (12 mg/mI) to that in whole
NTS. To exclude the further possibility of non-an-
tibody NTS-induced permeability factors generated
in vivo, serum from groups of five guinea pigs injected
with NTS was collected ten minutes, one, and four
hours after NTS injection, pooled, and immediately
reinjected i.v. and i.p. in amounts up to 12 ml into
normal guinea pigs with subsequent measurement of
urine protein and biopsy 24 hr later. Age and weight-
matched control animals for all studies were injected
with equivalent amounts of pooled normal sheep se-
rum or normal sheep IgG.
C' and PMN studies. C4 deficient guinea pigs were
screened for the absence of C4 before use by a
hemolytic assay [16]. Total hemolytic complement
(C'H50) levels were measured as described by Kabat
and Mayer [22]. C' depletion was accomplished by
i.p. injection of purified cobra venom factor (lot
#50104, Cordis Corporation, Miami, FL), 250U
per animal in four divided doses, 24 hr prior to NTS
injection [23]. Adequacy of C' depletion at the time
of injection and 24 hr later was confirmed by C'H50
levels and absence of detectable C3 by immunodiffu-
sion [23]. In vitro C' fixation was tested by an indirect
immunofluorescence method [24] using fresh human
and guinea pig serum as C' sources and fluorescein-
conjugated antisera to human and guinea pig C3 (see
following). As a positive control, inactivated human
serum containing anti-nuclear antibody was reacted
with cryostat sections of normal guinea pig kidney.
The deposited human anti-nuclear antibody readily
fixed C' in vitro from fresh human and guinea pig se-
rum by this technique [12]. The effect of PMN-deple-
tion was studied 72 hr after a single i.v. injection of 2.0
mg of nitrogen mustard per kg of body wt [25] at which
time circulating PMN counts determined by standard
counting chamber techniques were < 150/mm3.
Drug studies. Untreated controls and guinea pigs
for drug studies weighed 150 to 230 g and received i.v.
0.03 ml/l00 g of body wt of NTS. Drugs were admin-
istered i.p. two hours before and again two hours
after NTS injection, unless otherwise specified. The
drugs and doses studied are listed in Table 3. Doses of
the vasoactive amine antagonists, cyproheptadine,
chiorpheniramine maleate, and promethazine hydro-
chloride, were selected on the basis of their ability to
completely inhibit the bluing reaction induced by
intradermal injections of up to 20zg of histamine
base or serotonin 30 mm after i.v. injection of 1.0 ml
of 0.5% Evans blue dye and 2 hr after administration
of the drugs [26]. Sodium heparin, 3000 U/kg of body
wt, given i.v. two hours before and six hours after
NTS, prolonged standard Lee-White clotting times to
over one hour for most of the 24-hr period following
NTS. Niridazole (lot #B75-8, Ciba-Geigey Corpora-
tion, Summit, NJ), 100 mg/kg of body wt in saline,
was given orally for seven days prior to NTS [27].
This regimen markedly reduced or abolished the de-
layed response to intradermal injection of 5tg of
purified tuberculoprotein (Connaught Medical Re-
search Laboratories, Willowdale, Ontario, Canada)
in animals sensitized with complete Freund's adju-
vant.
Active and passive enhancement studies. In an effort
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to induce a second phase of proteinuria four or more
days after recovery from an initial dose of 0.03 to 0.05
ml of NTS per 100 g of body wt, five groups of ten
animals each were: a) actively immunized with
weekly injections of sheep IgG in complete Freund's
adjuvant starting at the time of NTS injection (one
group), the sheep IgG antigen containing both y1 and
'y2 fractions by immunoelectophoresis; h) injected
passively i.v. 4 or 14 days after NTS administration
with up to 5 ml of guinea pig (two groups) or rabbit
(two groups) antibody to sheep IgG with precipitin
titers of 1: 128 or greater. Precipitin analysis of anti-
body to sheep lgG was carried out by mico-Ouchter-
lony techniques in 1% agarose against an antigen con-
centration of 1 mg/mI. Several animals received three
to five repeated injections of antibody at two-day
intervals.
Light microscopy. Formalin-fixed tissue was
stained with hematoxylin and eosin stain, periodic
acid-Schiff stain, Fraser-Lendrum fibrin stain, col-
loidal iron at a pH of 1.8, and Alcian blue at a pH of
1.6 [281. Polymorphonuclear leukocytes were
counted in 20 or more 4-es sections of centrally-sec-
tioned glomeruli.
Immunofluorescence. Immunofluorescence tech-
niques, reagent characterization, and controls have
been described elsewhere [29]. Fluoresceinated anti-
sera to guinea pig IgG, including 'y' and Y2 sub-
classes, C3, fibrin, and albumin were prepared as
previously described [12, 14], Additional antisera to
human IgG, C3, and sheep IgG were obtained com-
mercially (Cappel Laboratories, Downington, PA).
Rabbit antisera to sheep 'Yi and Y2 subclasses were
made by immunization with the respective fractions
isolated by chromatography of a 50% ammonium
sulfate precipitate of normal sheep serum on DEAF-
Sephadex as described by Henson [30]. Antisera to
guinea pig C4 was produced in rabbits by immuniza-
tion with functionally purified guinea pig C4 (Cordis
Laboratories) and made monospecific by absorption
with serum from C4-deficient guinea pigs. All rea-
gents were determined to be monospecific by im-
munoelectrophoresis and micro-Ouchterlony tech-
niques, had fluorescein to antibody ratios of 0.135 to
0.155, and were adjusted to precipitin titers of 1:4
before use.
Electron microscopy. Techniques for electron mi-
croscopy and ultrastructural tracer studies using fer-
ritin have been described elsewhere [13]. Tissue was
fixed in glutaraldehyde, post-fixed in osmium for 60
mm, followed by en bloc fixation in uranyl acetate for
30 mm before embedding in Epon 812. GBM per-
meability to ferritin was evaluated 15, 30, 60, and 120
mm, and at 4 hr after NTS injection by i.v. adminis-
tration of 2 ml of cadmium-free horse spleen ferritin
(Nutritional Biochemicals, Chagrin Falls, OH), 100
mg/mi, prepared as described by Farquhar, Wissig,
and Palade [31] and given 15 to 30 mm prior to
biopsy and immersion fixation of tissue.
Results
1. Heierologous phase of guinea pig nephrotoxic nephritis
(NTN)(daysl to6)
Froteinuria, GBM permeability, and renal function.
Absorbed sheep nephrotoxic serum (NTS) contained
12.4 mg/mI of sheep IgG with both 'y' and Y2 sub-
classes present by immunodiffusion [25]. In 250 g
guinea pigs, proteinuria was induced by injection of
0.015 ml of NTS/lOO g of body wt and increased up
to a dose of 0.03 ml/lOOg. This dose induced a mean
urine protein excretion of 308 125 mg (range, 105
to 534 mg) in the 24-hr period following NTS injec-
tion (Fig. 1). Larger doses did not produce linear
increments in proteinuria (Fig. 1). Moreover, doses
of up to 1.0 ml/lOO g did not result in any histologic,
immunofluorescence, or electron microscopic
changes different from those described below. The
dose-response curve using purified IgG from NTS
was essentially superimposable on that for whole se-
rum. A dose of 0.03 ml of NTS/lOO g was then used
for all subsequent studies. Although a 1 to 2-hr pe-
riod of oligoanuria regularly followed NTS injection,
increased protein excretion was detected in the
earliest urine specimens obtained directly from the
bladder at 2 to 3 hr. The rate of protein excretion was
maximal at 5 to 6 hr, had decreased markedly by 18
to 24 hr, and was back to normal levels by 48 hr
(Table 1). The time course of proteinuria induced by
NTS, changes in serum creatinine, blood urea nitro-
gen (BUN), and glomerular immunofluorescence de-
500
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Dose of sheep serum, mI/100 g
Fig. 1. Dose-response curve for pro teinuria induced by nephrotoxic
serum (Ni'S).
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Hours after
NTS m
Protein excretion,
g/hr, mean SE/ti
C'H50, % of
normaP
—6toO(control) 0.026 + 0.013 (8)' 100 4
Otol 82+12lto2 —C 78 + 14
2to3 0.56 0.22 (4) 81 + 14
3to4 18.4 + 8.1 (5) 87 12
4to5 20.9 + 10.4 (5) 90 + 6
5to6 26.3 + 12.1 (5) 92 + 5
6to12 22.4 + 8.1 (6) 97 6
l2to 18 12.7 + 4.1 (5) 95 + 4
l8to24 8.2 3.1 (6) 92 + 6
24 to 30 4,8 + 1.8 (6)
30to36 1.2 0.4 (6)
36to48 0.21 0.12 (6)
at end of each time period.
bNumber of animals.
cMeasurements not made due to low urine flow rate.
posits are shown in Figure 2. Agarose gel elec-
trophoresis of concentrated urinary protein revealed
89 4% albumin, with only slight increases in the
concentrations of other classes of serum proteins
A
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compared to normal urine (Fig. 3). Control animals
injected with equivalent doses of normal sheep serum
had no measurable increase in urine protein (Fig. 2).
Up to 12 ml of fresh pooled serum obtained 10mm, 1
and 4 hr after NTS also did not induce measurable
increases in urine protein excretion in normal guinea
pigs.
Renal functional impairment manifested by a
doubling of the serum creatinine concentration and
comparable rise in BUN was apparent 24 hr after
NTS injection (Fig. 2). These values had returned to
normal levels six days later.
Histology and histochemistry. Morphologic study
of glomeruli at 1, 2, 3,4, 6, 8, and 24 hr after NTS
injection revealed no detectable histologic changes
(Fig. 4). Hourly glomerular polymorphonuclear leu-
kocyte (PMN) counts revealed maximal values of less
than one PMN/glomerulus and were not different in
experimental and control animals. Fibrin deposition
and crescent formation were never seen. Results of
histochemical staining for glomerular polyanion by
the Alcian blue and colloidal iron methods were com-
parable. Although no reduction in staining was ap-
parent prior to the onset of proteinuria, staining was
reduced at 24 hr in animals receiving NTS compared
to controls (Fig. 5, A and B). In biopsy specimens
obtained 5 to 7 days after NTS injection, colloidal
Table 1.Hourly urine protein excretion and total hemolytic
complement (C'H0) values following nephrotoxic serum
(NTS) injection
Days Weeks
Proteinuria, mg/day (mean SEMI
(mean sEMI
1.5' Serum creatinine, mg/lOOm/ (mean SEMI
I I I I
0 1 2 3 4 5 6 7 2 4 6 8 10 12
Days Weeks
Fig. 2. Time course of proteinuria, immuno,fluorescence deposits of
sheep and guinea pig IgG and guinea pig C3. and B UN and creatinine
in normal guinea pigs following one dose of nephrotoxic serum
(NTS).
lb.
Fig. 3. A. .4garose gel electrophoresis of normal guinea pig urine; B,
urine fi-oni guinea pigs with nephrotoxic nephritis (NTN); and C,
normal guinea pig eruu7 at equivalent protein concentrations (60
ing/mi). AIb = albumin.
B C
—p
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iron and Alcian blue staining had returned to normal
intensity.
Immunqfluorescence. Sheep IgG of both the Yi and
subclasses was bound to the GBM of all glomeruli
in a linear pattern within ten minutes of NTS injec-
tion (Fig. 6A). No binding of IgG to extraglomerular
sites in the kidney was detectable. No guinea pig C3
or C4 was detectable on the GBM at any time after
NTS injection (Fig. 6, B and C). Small amounts of C3
and C4 and guinea pig IgG were sometimes present in
a granular pattern in the mesangium as previously
reported [12, 13]. Mesangial C3 was present in in-
creased amounts one to two weeks after NTS injec-
tion, but returned to control levels thereafter. Guinea
pig albumin was present as reabsorption droplets in
proximal tubules of animals studied more than one
hour after NTS injection, but was never seen along
the GBM. No deposits of guinea pig IgG or fibrin
were seen outside of the mesangium during the six
days following NTS injection.
Electron microscopy and tracer studies. Electron
microscopy (EM) of glomeruli at intervals up to 24 hr
after NTS injection revealed only focal fusion of epi-
thelial cell foot processes seen as early as 30 mm and
more apparent by 4 hr (Fig. 7). The GBM itself was
entirely normal except for rare focal areas of rarefac-
tion. Endothelium and mesangial areas were unre-
markable (Fig. 7). Endothelial cell displacement,
PMN infiltration, deposits of fibrin, and structural
GBM changes [13] were not observed (Fig. 7). No
significant EM lesions were seen in animals studied
later than 48 hr after NTS or during the phase of
autologous antibody deposition.
EM tracer studies failed to reveal any increase in
GBM permeability to ferritin at any point following
antibody injection, including the period at 4 hr when
the rate of urine protein excretion was near maximal
levels (Fig. 7).
C' and polymorphonuclear leukocyte (PMN)-de-
pletion. Cryostat sections of guinea pig kidney with
sheep nephrotoxic antibody deposits failed to fix
guinea pig C3 or C4 in vitro, although both C3 and
C4 were readily fixed by human antinuclear antibody
using the same substrate and technique.
Total hemolytic complement (C'H50) levels mea-
sured at 1,2,3,4,5,6,12, 18, and 24 hr after injection
of NTS showed a small but insignificant decrease at I
to 3 hr, but were otherwise within normal limits
(Table 1).
Guinea pigs pretreated with cobra venom factor had
< 5% of normal C'H50 levels and no detectable C3 by
immunodiffusion at the time of NTS injection and 24
hr later (Table 2). Proteinuria during the 24 hr after
NTS injection did not differ significantly in C'-de-
Fig. 4. Glomerulusfro,n heavily proteinuric guinea pig injected four
hours previously with nephrotoxic serum (NTS). No poiy-
morphonuclear leukocyte infiltrate or other histologic abnor-
malities are present (Periodic acid-Schiff, X 500).
pleted and untreated age and weight-matched con-
trols (Table 2). Results in C4-deficient guinea pigs
were also not statistically significantly different from
those in normal and C'-depleted animals (Table 2).
Guinea pigs depleted of circulating PMN's to levels
of < 150/mm3 also showed no reduction in protein-
uria induced by NTS (Table 2). Histologic, immu-
nofluorescence, and EM studies in representative C'-
depleted, C4-deficient, and PMN-depleted guinea
pigs did not differ from those described above.
Drug pretreatment studies. Urine protein excretions
in the 24 hr following NTS injection of guinea pigs
pretreated as described with the agents listed are
tabulated in Table 3. None of the drug pretreatment
regimens employed resulted in any significant reduc-
tion in proteinuria induced by NTS.
Fig. 5. A, Glomeruli from representative guinea pigs 24 hr after
injection of normal sheep serum,' B, after injection of NTS, stained
with colloidal iron at pH 1.8 showing reduced GBM staining for
polvanion in nephrotoxic animal (X 480).
1'
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Fig. 6. A, Inimunofluorescence staining Jr sheep y B, guinea pig 1lc—(3la (C3);and C, guinea pig C4 24 hr after NTS injection showing linear
deposition of sheep IgG without fixation of guinea pig C3 or (4. D, Ten days later, heavy linear deposits of guinea pig Y2 are present on the
GBM. [>< 750 (A), 450 (B, C, D).]
I!. A utologous phase of guinea pig nephrotoxic nephritis
(NTN) (days 7 (080)
Immunofluorescence. Linear deposition of guinea
pig IgG, predominantly of the '/2 subclass, was first
detectable along the GBM in 1 to 2+ amounts 7 days
after NTS injection and increased in intensity there-
after (Fig 2 and 6D). Although faint staining for Yi
was present after 14 days, the autologous phase GBM
deposits always appeared to be predominantly 'Y2.
Despite the heavy deposition of guinea pig Ig on the
GBM after day 7, no GBM deposition of C3 or C4
could be detected at any time during the autologous
phase. Traces of fibrin along with IgG, C3, and C4
were present in the mesangium at 7 and 14 days.
Although small amounts of human C3 were fixed in
vitro by these mesangial deposits, no in vitro fixation
of human or guinea pig C3 by GBM deposits was
demonstrable in sections of kidneys studied between
days 7 and 80.
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Fig. 7. Electron micrograph 4 hr after fNTS injection and 15 mm after
ferritin injection. There is focal fusion of epithelial cell (EP) foot
processes. No significant abnormalities are seen in the endothelium
(EN) or GBM. There is no increase in GBM permeability to
Renal function and pathology. Despite the deposi-
tion of guinea pig Ig on the GBM starting at day 7,
there was no detectable loss of renal function, in-
crease in urine protein excretion, or appearance of
significant histologic or EM abnormalities in animals
injected with NTS alone and followed for up to 12
weeks (Fig. 2).
Effect of active and passive immunization on the
autologous phase. Although all guinea pigs treated
with sheep NTS subsequently manifested linear
GBM deposits of autologous IgG after day 7, none
had circulating antibody to sheep lgG by immuno-
precipitin analysis. Active immunization with sheep
IgG produced detectable circulating levels of autol-
ogous antibody to sheep IgG in 1 to 2 weeks, which
ranged in titer from 1:8 to 1:64, and persisted
for 8 to 10 weeks. Although immunized animals had
some increase in intensity of autologous GBM an-
tibody deposits by immunofluorescence, no deposi-
tion of C3 or C4, proteinuria, or histologic changes
developed in these animals when followed for up to
16 weeks.
Single and repeated passive administration of both
homologous guinea pig and heterologous rabbit an-
tibody to sheep IgG 4 and 14 days after NTS injec-
tion also failed to induce C3 or C4 fixation in glome-
ruli, proteinuria, or histologic changes, although 4+
linear deposits of the injected rabbit or guinea pig
IgG were demonstrable in glomeruli by immunofluo-
rescence minutes after injection on day 4, and circu-
lating antibody levels persisted for several days.
Discussion
This study demonstrates that in the guinea pig
nephrotoxic nephritis (NTN) model a marked in-
crease in GBM permeability is induced by deposition
of circulating heterologous IgG without participation
Normal
C'-
depleted
C4-
deficient
PMN-
depleted
No. of animals 10 10 8 10
Serum C'H50,
% of normal + SD 100 7 4 3 AbsentC4 97 + 8
Proteinuria,
mg/day/IOU g
Mean 135 149 III 126
SI) 48 37 41 39
P value — >0.1 >0.1 >0.1
ferritin granules which are confined to the capillary lumen and
inner layers of the GBM. BM = basement membrane; CL =
capillary lumen; US = urinary space. (X 39,200).
Table 2. Proteinuria in normal, C-depleted, C4-deficient, and
polymorphonuclear leukocyte (PMN)-depleted guinea pigs
in first 24 hr after injection with 0.03 ml/lOO g of body wt of
nephrotoxic serum
a< 150/mm3
bUrine protein in normal guinea pigs = < 5 mg/day.
! I,
em -.
.. -:
r
• 'i/-
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Table 3. Effect of drug pretreatment on proteinuna induced in first 24 hr following 0.03 mI/IOU g of body wt of nephrotoxic serum
Agent Dosea
mg/kg
No. of
animals
Mean urine
protein
mg/day + SD
Range P
Control — 27 308 125 105 to 534
Methylprednisolone 20 9 351 + 133 186 to 602 >0.1
Azathioprine 10 10 324 + 153 79 to 602 >0.1
Colchicine 1.0 6 292 112 92 to 483 >0.1
Aspirin 100 10 309 91 110 to 512 >0.1
Indomethacin 4.0 10 218 + 108 81 to 510 >0.1
Heparin 30 6 233 + 113 84 to 425 >0.1
Aprotinin(Trasylol) 100,000 (KIU) 9 297 + 105 72 to 456 >0.1
Promethazine 10 10 311 + 121 112 to 570 >0.1
Chlorpheniramine 10 12 387 + 148 147 to 685 >0.1
Cyproheptadine 1
5
10
10
10
24
283 + 136
271 111
299 + 93
149 to 568
117 to 491
108 to 595
>0.1
>0.1
>0.1
Niridazole 100k 11 306 + 117 119 to 512 >0.1
aDrug doses given i.p. 2 hr before and 4 hr after NTS injection.
bDaily oral dose for 7 days before NTS injection.
of complement (C'), polymorphonuclear leuko-
cytes (PMN), or other known medtators of im-
munologic tissue injury, including vasoactive amines,
kinins, prostaglandins, the coagulation system, or
substances released by sensitized lymphocytes. The
only pathologic changes detected following NTS ad-
ministration were fusion of epithelial cell foot proc-
esses and decreased glomerular affinity for cationic
stains. These studies confirm and extend observations
on NTN in the guinea pig, as reported by Simpson et
a!, who demonstrated that induction of proteinuria in
this model requires only the bivalent F(Ab')2 frag-
ment of sheep 'Yi or Y2 globulin [14]. Anti-GBM
antibody-induced proteinuria in the guinea pig NTN
model thus appears to be mediated by a fundamen-
tally different mechanism from that in the rat and
rabbit [32] where proteinuria can be substantially
reduced or abolished by depletion of C' [2, 3] or
PMN [4, 5J prior to nephrotoxic serum (NTS) injec-
tion and can be restored by PMN reconstitution [5].
Proteinuria has been observed following administra-
tion of nephrotoxic antibody to animals congenitally
deficient in [33—35] or selectively depleted of [4, 25,
34] C' components, and is induced without C' activa-
tion by avian anti-GBM antibody [2], sheep Yz [14,
30], guinea pig [36, 37], and the F(Ab')2 fragments
of sheep and guinea pig y' [14, 37] globulins. In most
of these models, however, C'-independent injury is a
minor component of more severe inflammatory gb-
merular lesions and is seen only at higher antibody
doses. Thus, C'-independent mechanisms of glomeru-
lar damage have not been easily isolated for study.
The guinea pig model is unique in manifesting
exclusively C'-independent nephropathy with mas-
sive but transient proteinuria induced by a small an-
tibody dose. The mechanism responsible for this
marked change in capillary wall permeability without
inflammation is unclear. Since proteinuria occurred
independently of C' fixation, PMN, and inflamma-
tory changes, was induced equally effectively with
IgG in purified form or whole serum, was not asso-
ciated with in vivo generation of demonstrable per-
meability increasing factors, and could not be in-
duced by single or repeated reactions of passively
administered antibody with GBM-bound sheep IgG,
these results suggest that the increase in capillary wall
permeability required only binding of IgG antibody
to specific GBM antigens.
Although the amount of GBM-bound IgG re-
quired to induce proteinuria was not quantitated in
this study, it has been reported by Simpson et alto be
l5g/kidney in this model [14]. The lowest dose of
NTS consistently producing proteinuria (0.0375 ml)
presumably contained at least that quantity of kid-
ney-fixing antibody, or about 6% nephrotoxic IgG, a
figure consistent with that reported by others [32].
These data suggest an approximately 5- to 6-fold
increased sensitivity to this form of glomerular injury
in the guinea pig compared to the rat [38]. Auto!-
ogous phase proteinuria, however, which has been
shown to be C'-independent in rabbits by Thompson
et al [39], can be induced in rats by passive adminis-
tration of antibody to as little as 2tg/kidney of
bound nephrotoxic globulin [40]. The amount of
GBM-bound IgG required to induce proteinuria n
the guinea pig is several-fold in excess of this. Hence,
the small initial dose of NTS in this model does not
adequately explain the resistance of this species to
autobogous phase proteinuria. The studies reported
here do not further clarify this phenomenon.
With regard to the mechanism of the initial NTS-
induced proteinuria, the transient increase in serum
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creatinine and BUN and the one- to two-hour period
of oliguria following antibody deposition are consistent
with an immediate decrease in renal plasma flow and
filtration rate following NTS. Marked decreases in
renal plasma flow, nephron filtration rate, and urine
flow have been documented during the early phase of
NTN in rats [41]. Theoretical considerations predict
[42] and physiologic studies demonstrate [8] a higher
fractional clearance of neutral macromolecules in the
size range of albumin at lower renal plasma flow
rates, presumably reflecting the contribution of diffu-
sion as well as bulk flow to transglomerular transport
of such molecules. Recent studies by Ryan, Kar-
novsky, and Hem, using in situ fixation techniques,
provide additional morphologic evidence of in-
creased penetration of albumin, IgG, and catalase
into and through GBM in conditions of reduced
blood flow [9, 431. Thus, transiently altered renal
hemodynamics may have contributed to the early
increase in transcapillary transport of albumin in this
model by similar mechanisms. The rapid reversibility
of such hemodynamic alterations could explain the
failure of proteinuria to persist, despite the continued
presence of antibody deposits [9, 43].
However, the quantitive changes in clearance of
albumin-sized molecules, demonstrated at low flow
rates in normal rats, are not alone adequate to fully
explain the greater than 1000-fold increase in rate of
urine protein excretion observed in the guinea pig six
hours after NTS when urine flow was restored [81.
Moreover, direct measurements of glomerutar hemo-
dynamics and ultrafiltration coefficients in NTN
rats demonstrate that the changes found are in-
sufficient to account for measured alterations in frac-
tional clearances of neutral dextrans in the size range
of albumin which are decreased rather than increased
[441. The simultaneous increased fractional clearance
of anionic dextran sulfate reported in NTN rats sug-
gests a second mechanism for the change in GBM
permeability which may apply to the guinea pig NTN
model; namely, that immunologic mechanism may
reduce net negative charge on the capillary wall,
thereby increasing permeability to anionic serum pro-
teins such as albumin [45]. Since NTN in rats is a C'-
dependent lesion [3, 9] and the latter studies were
carried out in the autologous phase of NTN during
or after a second immunologic reaction within the
glomerulus [45], these results in rats cannot con-
fidently be utilized to interpret our data or explain the
mechanism of immediate C'-independent antibody
effect on guinea pig GBM. However, our findings
that affinity for cationic stains was decreased 24 hr
after antibody deposition (a change which in our
laboratory has not been associated with proteinuria
alone [461) and that albumin was the principal pro-
tein excreted in the urine after NTS are consistent
with an antibody-induced reduction in fixed negative
charge on the capillary wall. In further support of this
suggestion are reports that nephrotoxic antibody can
reduce colloidal iron staining in vitro E47], presumably
independently of C' or inflammatory changes, and
that neutralization of glomerular polyanion by per-
fusion with polycations rapidly induces changes in
epithelial cell morphology similar to those seen
within 30 mm of antibody injection in this study [481.
Whether proteinuria in the guinea pig accompanied
or followed these epithelial cell changes could not be
conclusively determined since the period of oliguria
following NTS injection precluded accurate measure-
ments of protein excretion for the first two hours.
Absorption studies have suggested that antibody ac-
tivity against sialoprotein-containing antigens is re-
quired to induce proteinuria [47]. If alterations in
capillary wall charge do result from C'-independent
nephrotoxic antibody deposition, this may result
from antibody reactivity with anionic antigenic sites,
either in sialoprotein coating of epithelial cells and
slit pores [47, 49, 50J or within the GBM and endo-
thelial cells [11,511. Charge-related alterations in epi-
thelial cell morphology are rapidly reversible [46].
The disappearance of foot process fusion and the
return of colloidal iron staining to normal after cessa-
tion of proteinuria in this model suggest that an
antibody-induced alteration in capillary wall charge
may be of sufficiently short duration to account for
the transient proteinuria despite persistence of detect-
able IgG deposited on the GBM by immunofluores-
cen cc.
The hypothesis that charge effects may contribute
to nephrotoxic antibody-induced proteinuria in this
model does not explain the failure to demonstrate
increased permeability to anionic native ferritin in
proteinuric guinea pigs, since a reduction in negative
charge should increase permeability to this tracer, as
shown in other proteinuric states [13, 52]. It is con-
ceivable that a marked increase in permeability to
smaller polycationic proteins such as albumin (60,000
daltons) may occur without significant change in pen-
etration of the much larger (550,000 daltons) ferritin
molecule, or that ferritin may be more restricted by
steric hinderance factors related to deposition of IgG
within the GBM.
It is now clear from studies in this and other mod-
els that binding of antibody to antigenic sites within
the GBM may have widely variable effects. Thus,
anti-GBM antibody in nephritogenic amounts may
bind in a linear pattern to GBM and induce no ap-
parent glomerular injury [12, 30] even when C' is
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activated [36], a result similar to that reported with
antibody to the collagen component of GBM alone
[53]. Proteinuria may require the presence of PMN's
and be abolished by PMN-depletion but unaltered by
depletion of C', as reported in the autologous phase
of NTN in rabbits [39, 54]. Under other circum-
stances, nephrotoxic antibody induces proteinuria
and glomerular inflammation by mechanisms that are
both C' and PMN-dependent as shown in the rat and
rabbit by others [3—5, 25, 30, 34]. Finally, our present
and earlier studies [12, 13] and those of Simp-
son et al [14] indicate that antibody deposition
alone can induce a marked alteration in GBM per-
meability independently of C', PMN's, and probably
other mediator systems. Although the relative impor-
tance of such non-inflammatory antibody effects in
human renal disease is presently undetermined, re-
cent clinical studies strongly suggest that a similar
range of effects and pathogenetic mechanisms may be
characteristic of anti-GBM nephritis in man as well
[55].
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